Clinical Trials on Heart Failure With Reduced Ejection Fraction NYHA Class III-IV in Sweden
Total 27 results
-
Region SkaneEnrolling by invitationHeart Failure New York Heart Association (NYHA) Class II | Heart Failure New York Heart Association (NYHA) Class IIISweden
-
Göteborg UniversityRecruitingHeart Failure With Reduced Ejection FractionSweden
-
French Cardiology SocietyCompletedCongestive Heart Failure | Heart Failure With Preserved Ejection Fraction | Left Ventricular Ejection FractionSweden, France
-
AnaCardio ABRecruitingHeart Failure With Reduced Ejection FractionUnited Kingdom, Sweden, Netherlands, Italy
-
EP Solutions SARecruitingHeart Failure With Reduced Ejection FractionSweden, Netherlands, Portugal, United Kingdom
-
CytokineticsCompletedHeart Failure With Reduced Ejection FractionUnited States, Hungary, France, Canada, Netherlands, Germany, Poland, Italy, Sweden
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection FractionHungary, Spain, Italy, United States, Germany, United Kingdom, Turkey, Slovakia, Bulgaria, Finland, Puerto Rico
-
AstraZenecaCompletedHeart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, Korea, Republic of, Brazil, Slovakia, Japan, South Africa, Sweden
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionBelgium, Estonia, Denmark, Greece, United Kingdom, Germany, Latvia, Lithuania, Spain, Netherlands, Bulgaria, Finland, Poland, Czechia, Iceland, Sweden, France, Ireland, Norway
-
BayerMerck Sharp & Dohme LLCRecruitingChronic Heart Failure With Reduced Ejection FractionSpain, United States, Argentina, Hungary, Italy, Poland, Sweden
-
KronikguneOdense University Hospital; Assuta Ashdod Hospital; Maccabi Healthcare Services... and other collaboratorsRecruitingHeart Failure NYHA Class III | Heart Failure NYHA Class IV | Chronic Obstructive Pulmonary Disease SevereDenmark, Germany, Israel, Spain, Sweden, United Kingdom
-
Linkoeping UniversityUnknownVitamin D Deficiency | Heart Failure With Reduced Ejection FractionSweden
-
Novartis PharmaceuticalsCompletedHeart Failure With Reduced Ejection FractionItaly, Czechia, Russian Federation, Saudi Arabia, Turkey, Belgium, Switzerland, United Kingdom, Spain, Canada, Lebanon, Germany, Slovakia, Portugal, France, Poland, Argentina, Norway, Sweden
-
Merck Sharp & Dohme LLCActive, not recruitingChronic Heart Failure With Reduced Ejection FractionChina, United States, Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czechia, Denmark, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Malaysia, Mexico, New Zealand, Peru and more
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionGermany
-
Novartis PharmaceuticalsTerminatedHeart Failure With Reduced Ejection FractionChina, Germany, United States, Colombia, Korea, Republic of, Romania, South Africa, Canada, Belgium, Estonia, Hungary, Italy, Russian Federation, Taiwan, Turkey, United Kingdom, Spain, France, Netherlands, Hong Kong, Bulgaria, Israel and more
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionIndia, Romania, Belgium, Czechia, Estonia, Hungary, Russian Federation, Taiwan, United Kingdom, Spain, Israel, Thailand, Canada, Korea, Republic of, United States, Bulgaria, Denmark, Netherlands, Philippines, Lithuania, Germany, T... and more
-
Uppsala UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research Institute and other collaboratorsRecruitingHeart Failure With Preserved Ejection FractionSweden, United States
-
AstraZenecaCompletedChronic Heart Failure With Reduced Ejection Fraction (HFrEF)United States, Canada, Denmark, United Kingdom, Czechia, Vietnam, Germany, Brazil, India, China, Japan, Taiwan, Netherlands, Bulgaria, Slovakia, Hungary, Poland, Russian Federation, Argentina, Sweden
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionColombia, Romania, United States, Austria, Belgium, Estonia, Turkey, Germany, Netherlands, Italy, Spain, Thailand, Argentina, France, Bulgaria, Hungary, Israel, Peru, Lithuania, Guatemala, India, Russian Federation, Denmark, Mexico, Slo... and more
-
AstraZenecaCompletedHeart Failure With Preserved Ejection FractionUnited States, France, Netherlands, Belgium, Taiwan, Slovakia, Japan, Czechia, Hungary, Australia, Bulgaria, Poland, Russian Federation, Brazil, Denmark, Turkey, Sweden, Canada
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionChina, Germany, United States, Colombia, South Africa, Italy, Austria, Belgium, Croatia, Romania, Taiwan, Japan, Netherlands, Denmark, France, Israel, Spain, Switzerland, Korea, Republic of, Argentina, Canada, United Kingdom, Bulgaria, Gree... and more
-
AstraZenecaCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States, Denmark, Italy, Canada, Korea, Republic of, Brazil, Slovakia, Japan, Bulgaria, South Africa, Sweden, Argentina
-
ActelionCompletedHeart Failure With Preserved Ejection FractionUnited States, Spain, United Kingdom, Poland, Germany, Israel, Austria, Czechia, Russian Federation, Denmark, Bulgaria, Hungary, France, Argentina, Brazil, Romania, Sweden
-
ActelionChiltern International Ltd.; Medidata Solutions; Frontier Science & Technology... and other collaboratorsTerminatedHeart Failure With Preserved Ejection Fraction and Pulmonary Vascular DiseaseUnited States, United Kingdom, Israel, Austria, Russian Federation, Germany, Poland, Denmark, Argentina, Brazil, Bulgaria, France, Hungary, Romania, Sweden
-
MyoKardia, Inc.CompletedDilated Cardiomyopathy | Heart Failure With Reduced Ejection FractionUnited States, France, United Kingdom, Sweden, Germany, Netherlands, Poland
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden